GILD - Gilead Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
85.56B
Enterprise Value 3
86.96B
Trailing P/E
32.24
Forward P/E 1
9.74
PEG Ratio (5 yr expected) 1
5.49
Price/Sales (ttm)
3.83
Price/Book (mrq)
4.16
Enterprise Value/Revenue 3
3.89
Enterprise Value/EBITDA 6
13.24

Trading Information

Stock Price History

Beta (3Y Monthly) 1.14
52-Week Change 3-0.30%
S&P500 52-Week Change 318.53%
52 Week High 370.50
52 Week Low 360.32
50-Day Moving Average 365.40
200-Day Moving Average 365.32

Share Statistics

Avg Vol (3 month) 35.83M
Avg Vol (10 day) 35.49M
Shares Outstanding 51.27B
Float 1.26B
% Held by Insiders 10.70%
% Held by Institutions 182.64%
Shares Short (Nov 15, 2019) 415.58M
Short Ratio (Nov 15, 2019) 42.52
Short % of Float (Nov 15, 2019) 41.22%
Short % of Shares Outstanding (Nov 15, 2019) 41.23%
Shares Short (prior month Oct 15, 2019) 413.92M

Dividends & Splits

Forward Annual Dividend Rate 42.52
Forward Annual Dividend Yield 43.76%
Trailing Annual Dividend Rate 32.46
Trailing Annual Dividend Yield 33.66%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4116.04%
Dividend Date 3Dec 30, 2019
Ex-Dividend Date 4Dec 12, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jan 28, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 12.04%
Operating Margin (ttm)23.06%

Management Effectiveness

Return on Assets (ttm)5.22%
Return on Equity (ttm)12.24%

Income Statement

Revenue (ttm)22.36B
Revenue Per Share (ttm)17.55
Quarterly Revenue Growth (yoy)0.10%
Gross Profit (ttm)17.27B
EBITDA 6.57B
Net Income Avi to Common (ttm)2.69B
Diluted EPS (ttm)2.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.15B
Total Cash Per Share (mrq)18.3
Total Debt (mrq)25.3B
Total Debt/Equity (mrq)122.01
Current Ratio (mrq)2.96
Book Value Per Share (mrq)16.27

Cash Flow Statement

Operating Cash Flow (ttm)8.91B
Levered Free Cash Flow (ttm)3.34B